Early Radiotherapy Dose Response and Lack of Hypersensitivity Effect in Normal Brain Tissue: a Sequential Dynamic Susceptibility Imaging Study of Cerebral Perfusion

Clinical Oncology

Volumn 19, Issue 8, 2007, Pages 577-587

  Price, S J ^a   Jena, R ^a   Green, H A L ^a   Kirkby, N F ^a,b   Lynch, A G ^a   Coles, C E ^a   Pickard, J D ^a   Gillard, J H ^a   Burnet, N G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Brain; low dose hypersensitivity; low grade gliomas; normal tissue dose response; perfusion MRI; radiotherapy

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; BRAIN REGION; BRAIN TISSUE; CANCER GRADING; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; REFERENCE VALUE; TREATMENT RESPONSE; TUMOR VOLUME; WHITE MATTER;

ADULT; BRAIN; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG HYPERSENSITIVITY; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION; PROSPECTIVE STUDIES; RADIOTHERAPY; TIME FACTORS;

EID: 34548221368     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.04.010     Document Type: Article

References (53)

1. Burnet N.G., Jefferies S.J., Benson R.J., Hunt D.P., and Treasure F.P. Years of life lost (YLL) from cancer is an important measure of population burden - and should be considered when allocating research funds. Br J Cancer 9 (2005) 241-245
2. Burnet N.G., Bulusu V.R., and Jefferies S.J. Management of primary brain tumours. In: Booth S., and Bruera E. (Eds). Palliative care consultations in primary and metastatic brain tumours (2004), Oxford University Press
3. Burger P.C., Dubois P.J., Schold Jr. S.C., et al. Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58 (1983) 159-169
4. Burger P.C., Heinz E.R., Shibata T., and Kleihues P. Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68 (1988) 698-704
5. Kelly P.J., Daumas-Duport C., Kispert D.B., Kall B.A., Scheithauer B.W., and Illig J.J. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66 (1987) 865-874
6. Lilja A., Bergstrom K., Spannare B., and Olsson Y. Reliability of computed tomography in assessing histopathological features of malignant supratentorial gliomas. J Comput Assist Tomogr 5 (1981) 625-636
7. Selker R.G., Mendelow H., Walker M., Sheptak P.E., and Phillips J.G. Pathological correlation of CT ring in recurrent, previously treated gliomas. Surg Neurol 17 (1982) 251-254
8. Hawighorst H., Schreiber W., Knopp M.V., et al. Macroscopic tumor volume of malignant glioma determined by contrast-enhanced magnetic resonance imaging with and without magnetization transfer contrast. Magn Reson Imaging 14 (1996) 1119-1126
9. Johnson P.C., Hunt S.J., and Drayer B.P. Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings. Radiology 170 (1989) 211-217
10. Lunsford L.D., Martinez A.J., and Latchaw R.E. Magnetic resonance imaging does not define tumor boundaries. Acta Radiol 369 Suppl (1986) 154-156
11. Watanabe M., Tanaka R., and Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34 (1992) 463-469
12. Mosskin M., Bergstrom M., Collins V.P., et al. Positron emission tomography with 11C-methionine of intracranial tumours compared with histology of multiple biopsies. Acta Radiol 369 Suppl (1986) 157-160
13. Mosskin M., Ericson K., Hindmarsh T., et al. Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30 (1989) 225-232
14. Fitzek M.M., Thornton A.F., Rabinov J.D., et al. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg 91 (1999) 251-260
15. Burnet N.G., Johansen J., Turesson I., Nyman J., and Peacock J.H. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer 79 (1998) 606-613
16. Pavy J.J., Denekamp J., Letschert J., et al., EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol 35 (1995) 11-15
17. Rubin P., Constine III L.S., Fajardo L.F., Phillips T.L., Wasserman T.H., and EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 35 (1995) 9-10
18. Malaise E.P., Lambin P., and Joiner M.C. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?. Radiat Res 138 (1994) S25-S27
19. Short S.C., Mitchell S.A., Boulton P., Woodcock M., and Joiner M.C. The response of human glioma cell lines to low-dose radiation exposure. Int J Radiat Biol 75 (1999) 1341-1348
20. Short S.C., and Joiner M.C. Cellular response to low-dose irradiation. Clin Oncol 10 (1998) 73-77
21. Corn B.W., Yousem D.M., Scott C.B., et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 74 (1994) 2828-2835
22. Steen R.G., Koury B.S.M., Granja C.I., et al. Effect of ionizing radiation on the human brain: white matter and gray matter T1 in pediatric brain tumor patients treated with conformal radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 79-91
23. Tsuruda J.S., Kortman K.E., Bradley W.G., Wheeler D.C., Van Dalsem W., and Bradley T.P. Radiation effects on cerebral white matter: MR evaluation. Am J Neuroradiol 8 (1987) 431-437
24. Hopewell J.W., Calvo W., Campling D., Reinhold H.S., Rezvani M., and Yeung T.K. Effects of radiation on the microvasculature. Implications for normal-tissue damage. Front Radiat Ther Oncol 23 (1989) 85-95
25. van der Kogel A.J. Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer 7 Suppl (1986) 207-217
26. Chang H.J., Maj J.G., Paris F., et al. ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med 11 (2005) 484-490
27. Chan Y.L., Yeung D.K., Leung S.F., and Cao G. Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain. J Magn Reson Imaging 10 (1999) 130-137
28. Fajardo L.F., Berthrong M., and Anderson R.E. Nervous System. In: Fajardo L.F., Berthrong M., and Anderson R.E. (Eds). Radiation pathology (2001), Oxford University Press
29. Tsui E.Y., Chan J.H., Leung T.W., et al. Radionecrosis of the temporal lobe: dynamic susceptibility contrast MRI. Neuroradiology 42 (2000) 149-152
30. Curran W.J., Hecht-Leavitt C., Schut L., Zimmerman R.A., and Nelson D.F. Magnetic resonance imaging of cranial radiation lesions. Int J Radiat Oncol Biol Phys 13 (1987) 1093-1098
31. Ostergaard L., Sorensen A.G., Kwong K.K., Weisskoff R.M., Gyldensted C., and Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 36 (1996) 726-736
32. Ostergaard L., Weisskoff R.M., Chesler D.A., Gyldensted C., and Rosen B.R. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36 (1996) 715-725
33. Smith A.M., Grandin C.B., Duprez T., Mataigne F., and Cosnard G. Whole brain quantitative CBF and CBV measurements using MRI bolus tracking: comparison of methodologies. Magn Reson Med 43 (2000) 559-564
34. Constine L.S., Konski A., Ekholm S., McDonald S., and Rubin P. Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 15 (1988) 319-330
35. Schultheiss T.E., Kun L.E., Ang K.K., and Stephens L.C. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31 (1995) 1093-1112
36. Wakisaka S., O'Neill R.R., Kemper T.L., Verrelli D.M., and Caveness W.F. Delayed brain damage in adult monkeys from radiation in the therapeutic range. Radiat Res 80 (1979) 277-291
37. Valk P.E., and Dillon W.P. Radiation injury of the brain. Am J Neuroradiol 12 (1991) 45-62
38. Esteve F., Rubin C., Grand S., Kolodie H., and Le Bas J.F. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 40 (1998) 279-286
39. Roelcke U., von Ammon K., Hausmann O., et al. Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy. J Neurol Neurosurg Psychiatr 66 (1999) 644-647
40. Bruehlmeier M., Roelcke U., Amsler B., et al. Effect of radiotherapy on brain glucose metabolism in patients operated on for low grade astrocytoma. J Neurol Neurosurg Psychiatr 66 (1999) 648-653
41. Wenz F., Rempp K., Hess T., et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. Am J Roentgenol 166 (1996) 187-193
42. Fuss M., Wenz F., Scholdei R., et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 48 (2000) 53-58
43. Kiselev V.G. On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI. Magn Reson Med 46 (2001) 1113-1122
44. Roberts T.P. Physiologic measurements by contrast-enhanced MR imaging: expectations and limitations. J Magn Reson Imaging 7 (1997) 82-90
45. Lee M.C., Cha S., Chang S.M., and Nelson S.J. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. J Magn Reson Imaging 21 (2005) 683-693
46. Calvo W., Hopewell J.W., Reinhold H.S., and Yeung T.K. Radiation induced damage in the choroid plexus of the rat brain: a histological evaluation. Neuropathol Appl Neurobiol 12 (1986) 47-61
47. Bussink J., Kaanders J.H., Rijken P.F., Raleigh J.A., and van der Kogel A.J. Changes in blood perfusion and hypoxia after irradiation of a human squamous cell carcinoma xenograft tumor line. Radiat Res 153 (2000) 398-404
48. Spence A.M., Graham M.M., O'Gorman L.A., Muzi M., Abbott G.L., and Lewellen T.K. Regional blood-to-tissue transport in an irradiated rat glioma model. Radiat Res 111 (1987) 225-236
49. Hong J.H., Chiang C.S., Campbell I.L., Sun J.R., Withers H.R., and McBride W.H. Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys 33 (1995) 619-626
50. Turesson I., Nyman J., Holmberg E., and Oden A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 36 (1996) 1065-1075
51. Burnet N.G., Elliott R.M., Dunning A., and West C.M.L. Radiosensitivity, radiogenomics and RAPPER. Clin Oncol 18 (2006) 525-528
52. Harney J., Shah N., Short S., et al. The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiother Oncol 70 (2004) 319-329
53. Marples B., Wouters B.G., Collis S.J., Chalmers A.J., and Joiner M.C. Low-dose hyper-radiosensitivity: a consequence of ineffective cell cycle arrest of radiation-damaged G2-phase cells. Radiat Res 161 (2004) 247-255